Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astronics (ATRO) Cash & Equivalents (2016 - 2025)

Astronics (ATRO) has disclosed Cash & Equivalents for 16 consecutive years, with $18.2 million as the latest value for Q4 2025.

  • Quarterly Cash & Equivalents rose 95.8% to $18.2 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $18.2 million through Dec 2025, up 95.8% year-over-year, with the annual reading at $18.2 million for FY2025, 95.8% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $18.2 million at Astronics, up from $13.5 million in the prior quarter.
  • The five-year high for Cash & Equivalents was $33.6 million in Q3 2021, with the low at $2.6 million in Q4 2022.
  • Average Cash & Equivalents over 5 years is $14.2 million, with a median of $12.1 million recorded in 2022.
  • The sharpest move saw Cash & Equivalents crashed 91.17% in 2022, then surged 371.12% in 2025.
  • Over 5 years, Cash & Equivalents stood at $29.8 million in 2021, then tumbled by 53.7% to $13.8 million in 2022, then crashed by 65.48% to $4.8 million in 2023, then skyrocketed by 95.23% to $9.3 million in 2024, then surged by 95.8% to $18.2 million in 2025.
  • According to Business Quant data, Cash & Equivalents over the past three periods came in at $18.2 million, $13.5 million, and $13.5 million for Q4 2025, Q3 2025, and Q2 2025 respectively.